US President Donald Trump announced Monday that AstraZeneca’s COVID-19 vaccine has reached Phase 3 clinical trials in the United States and is very close to being finalized for approval.
“I am pleased to announce that the AstraZeneca vaccine has reached phase 3 clinical trials and has joined several vaccines that are very close to completion. In the United States, we are doing things that people thought were not possible,” said Trump. in a press. conference.
He said that process could have taken years, but his administration did it in a matter of months.
AstraZeneca also announced that its vaccine, developed by researchers at the University of Oxford, will enroll approximately 30,000 adult volunteers at 80 sites in the US.
“Trial centers in the US are recruiting up to 30,000 adults 18 years of age and older from various racial, ethnic, and geographic groups who are healthy or have stable underlying medical conditions, including those living with HIV, and who have an increased risk of infection from the SARS-CoV-2 virus, “AstraZeneca said in a statement.
The phase 3 trial is being rolled out as part of Operation Warp Speed in the US, which aims to deliver 300 million doses of a safe and effective vaccine for COVID-19 by January 2021.
The AstraZeneca injection is one of the leaders in the race to develop the Covid-19 vaccine. Other companies that have Covid-19 vaccines in phase 3 trials include Moderna Inc. and Pfizer Inc.
.
